vs

Side-by-side financial comparison of RB GLOBAL INC. (RBA) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× RB GLOBAL INC.). Zimmer Biomet runs the higher net margin — 11.4% vs 9.1%, a 2.3% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 5.4%). Zimmer Biomet produced more free cash flow last quarter ($245.9M vs $186.5M). Over the past eight quarters, RB GLOBAL INC.'s revenue compounded faster (6.3% CAGR vs 3.7%).

Ritchie Bros. Auctioneers (RBA), or simply Ritchie Bros., is a publicly traded company legally domiciled in Canada with headquarters in Westchester, Illinois. Its common shares are traded on the Toronto Stock Exchange and the New York Stock Exchange.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

RBA vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.7× larger
ZBH
$2.1B
$1.2B
RBA
Growing faster (revenue YoY)
ZBH
ZBH
+3.9% gap
ZBH
9.3%
5.4%
RBA
Higher net margin
ZBH
ZBH
2.3% more per $
ZBH
11.4%
9.1%
RBA
More free cash flow
ZBH
ZBH
$59.4M more FCF
ZBH
$245.9M
$186.5M
RBA
Faster 2-yr revenue CAGR
RBA
RBA
Annualised
RBA
6.3%
3.7%
ZBH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RBA
RBA
ZBH
ZBH
Revenue
$1.2B
$2.1B
Net Profit
$109.7M
$238.3M
Gross Margin
64.6%
Operating Margin
14.7%
17.9%
Net Margin
9.1%
11.4%
Revenue YoY
5.4%
9.3%
Net Profit YoY
-7.4%
30.5%
EPS (diluted)
$0.53
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RBA
RBA
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$1.2B
$2.2B
Q3 25
$1.1B
$2.0B
Q2 25
$1.2B
$2.1B
Q1 25
$1.1B
$1.9B
Q4 24
$1.1B
$2.0B
Q3 24
$981.8M
$1.8B
Q2 24
$1.1B
$1.9B
Net Profit
RBA
RBA
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$109.7M
$139.4M
Q3 25
$95.5M
$230.9M
Q2 25
$109.8M
$152.8M
Q1 25
$113.4M
$182.0M
Q4 24
$118.5M
$239.5M
Q3 24
$76.1M
$249.1M
Q2 24
$111.1M
$242.8M
Gross Margin
RBA
RBA
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
RBA
RBA
ZBH
ZBH
Q1 26
17.9%
Q4 25
14.7%
6.9%
Q3 25
14.5%
17.6%
Q2 25
15.9%
14.4%
Q1 25
17.1%
15.3%
Q4 24
18.1%
19.2%
Q3 24
15.6%
15.3%
Q2 24
18.4%
18.1%
Net Margin
RBA
RBA
ZBH
ZBH
Q1 26
11.4%
Q4 25
9.1%
6.2%
Q3 25
8.7%
11.5%
Q2 25
9.3%
7.4%
Q1 25
10.2%
9.5%
Q4 24
10.4%
11.8%
Q3 24
7.8%
13.7%
Q2 24
10.1%
12.5%
EPS (diluted)
RBA
RBA
ZBH
ZBH
Q1 26
$1.22
Q4 25
$0.53
$0.71
Q3 25
$0.43
$1.16
Q2 25
$0.53
$0.77
Q1 25
$0.55
$0.91
Q4 24
$0.58
$1.18
Q3 24
$0.36
$1.23
Q2 24
$0.54
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RBA
RBA
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$531.5M
$424.2M
Total DebtLower is stronger
$2.3B
$7.5B
Stockholders' EquityBook value
$5.6B
$12.7B
Total Assets
$12.1B
$22.7B
Debt / EquityLower = less leverage
0.42×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RBA
RBA
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$531.5M
$591.9M
Q3 25
$674.7M
$1.3B
Q2 25
$710.2M
$556.9M
Q1 25
$578.1M
$1.4B
Q4 24
$533.9M
$525.5M
Q3 24
$650.7M
$569.0M
Q2 24
$599.5M
$420.1M
Total Debt
RBA
RBA
ZBH
ZBH
Q1 26
$7.5B
Q4 25
$2.3B
Q3 25
$2.6B
Q2 25
$2.6B
Q1 25
$2.6B
Q4 24
$2.6B
Q3 24
$2.7B
Q2 24
$2.8B
Stockholders' Equity
RBA
RBA
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$5.6B
$12.7B
Q3 25
$5.5B
$12.8B
Q2 25
$5.5B
$12.5B
Q1 25
$5.3B
$12.4B
Q4 24
$5.2B
$12.5B
Q3 24
$5.2B
$12.4B
Q2 24
$5.2B
$12.7B
Total Assets
RBA
RBA
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$12.1B
$23.1B
Q3 25
$12.2B
$23.5B
Q2 25
$12.2B
$22.9B
Q1 25
$11.9B
$22.2B
Q4 24
$11.8B
$21.4B
Q3 24
$11.9B
$21.7B
Q2 24
$12.1B
$21.5B
Debt / Equity
RBA
RBA
ZBH
ZBH
Q1 26
0.59×
Q4 25
0.42×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.50×
Q3 24
0.52×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RBA
RBA
ZBH
ZBH
Operating Cash FlowLast quarter
$255.2M
$359.4M
Free Cash FlowOCF − Capex
$186.5M
$245.9M
FCF MarginFCF / Revenue
15.5%
11.8%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
2.33×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$719.2M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RBA
RBA
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$255.2M
$517.4M
Q3 25
$239.7M
$418.7M
Q2 25
$326.5M
$378.2M
Q1 25
$156.8M
$382.8M
Q4 24
$184.5M
$506.3M
Q3 24
$285.4M
$395.7M
Q2 24
$337.3M
$369.4M
Free Cash Flow
RBA
RBA
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$186.5M
$442.6M
Q3 25
$188.5M
$363.7M
Q2 25
$241.7M
$328.1M
Q1 25
$102.5M
$338.2M
Q4 24
$127.9M
$454.8M
Q3 24
$248.5M
$351.2M
Q2 24
$308.6M
$316.7M
FCF Margin
RBA
RBA
ZBH
ZBH
Q1 26
11.8%
Q4 25
15.5%
19.7%
Q3 25
17.3%
18.2%
Q2 25
20.4%
15.8%
Q1 25
9.2%
17.7%
Q4 24
11.2%
22.5%
Q3 24
25.3%
19.3%
Q2 24
28.2%
16.3%
Capex Intensity
RBA
RBA
ZBH
ZBH
Q1 26
Q4 25
5.7%
3.3%
Q3 25
4.7%
2.7%
Q2 25
7.2%
2.4%
Q1 25
4.9%
2.3%
Q4 24
5.0%
2.5%
Q3 24
3.8%
2.4%
Q2 24
2.6%
2.7%
Cash Conversion
RBA
RBA
ZBH
ZBH
Q1 26
1.51×
Q4 25
2.33×
3.71×
Q3 25
2.51×
1.81×
Q2 25
2.97×
2.48×
Q1 25
1.38×
2.10×
Q4 24
1.56×
2.11×
Q3 24
3.75×
1.59×
Q2 24
3.04×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RBA
RBA

Buyer Revenue$577.2M48%
Seller Revenue$255.2M21%
CA$199.0M17%
Other$124.7M10%
AU$47.3M4%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons